The condition already costs U.S. employers more than $245 billion per year, and prevalence is growing.

Part-time workers and employees at smaller businesses are less likely to have paid family and sick leave benefits, according to KFF.

GLP-1 spending increased by nearly 84%, compared with a 9.6% growth rate for all other retail drugs.

"The No Surprises Act has been an overwhelming success when it comes to protecting patients from surprise medical bills," said Rep. Frank Pallone Jr. (D-N.J.).